
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,...

Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have...

Review places silicone and occlusion as first‑line topical therapy, with retinoids, pressure, corticosteroids and cannabinoids as situational tools amid limited high‑quality evidence Scarring reflects replacement of normal dermis by fibroblast-driven,...

Efficient history, targeted exam, selective labs and clear shared‑decision plans let dermatologists deliver meaningful vitiligo care in time‑pressed visits In routine practice, non‑segmental vitiligo (NSV) visits can be both brief...